News & Updates

Company News

Exclusive Option Agreement for NXP001 in Oncology

Nuformix a pharmaceutical development company focused on unlocking the therapeutic potential and value of knowndrugs to develop novel medicines to provide enhanced benefit, announces it has signed an exclusiveoption agreement with Oxilio Ltd (“Oxilio”) Read more

Related stories

Read More

Park Members among finalists at Cambridge Independent Science & Technology Awards

Three Park members are among the finalists at this year’s Cambridge Independent Science and Technology Awards, with recognition for Jumptech ...

Read More

Xampla’s plastic-free push across Europe continues

Xampla has expanded the rollout of its plastic-free Morro Coating, with new takeaway boxes now available across 10 additional European ...

Read More

Global Leader in Online Child Safety joins Cambridge Science Park

The Park community continues to grow with the arrival of the Internet Watch Foundation (IWF), a global leader in online ...

Want to see your news featured here? Contact the team and let’s spread the word.

Get in touch with our team